“…In our previous work, we summarized that ROS may regulate the expression of ABL1 by triggering receptor tyrosine kinases (RTKs), which subsequently led to the phosphorylation of ABL1. NF- κ B1 and STAT3 were the main factors involved in cytokine release [29, 30], and both NF- κ B1 and STAT3 were proven to be downstream targets of ABL1 in leukemia [31, 32]. Here, we treated SGC-7901 and AGS GC cell lines with different concentrations of H 2 O 2 (0 μ M, 25 μ M, and 50 μ M), and the result showed that ROS could enhance the activities of ABL1 and could upregulate p-NF- κ B1, p-STAT3, IL-6, IL-1 β , and COX2 (Figure 2(a)).…”